Skip to content

A Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy

A Prospective Observational Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07288710
Enrollment
316
Registered
2025-12-17
Start date
2023-03-09
Completion date
2026-04-20
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lobectomy, Lung Cancer (Diagnosis), Sublobar Resection

Brief summary

The trial was designed as a single-center, non-interventional, prospective observational study to explore the role of a multimodal digital device in analyzing subjective and objective recovery in lung cancer patients undergoing sublobar resection versus lobectomy.

Interventions

None listed

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. adult patients (age ≥ 18 years) 2. American Society of Anesthesiologists (ASA) grade of III or below 3. scheduled for VATS from March to December 2023

Exclusion criteria

1. age \<18 years 2. inability or poor compliance to use wearable devices 3. lack of smartphone 4. incomplete digital device data during hospitalization 5. patients with lymph node or distant metastasis

Design outcomes

Primary

MeasureTime frameDescription
Electronic patient-reported outcomesFrom 1 day prior to surgery through hospital discharge (assessed up to 15 days).The electronic patient-reported outcomes questionnaire includes pain, cough, shortness of breath, restless sleep, fatigue, drowsiness, walking difficulties, activity limitation, and distress(0 = no symptom, 10 = most severe).

Secondary

MeasureTime frameDescription
Length of Hospital StayFrom the day of surgery until the day of discharge, assessed up to 15 days.Total number of days spent in the hospital from admission to discharge.
Surgical TimeDuring the surgical procedure (from anesthesia induction until skin closure).Duration of the surgery measured in hours.
Number of Lymph Nodes DissectedDuring the surgical procedure (from anesthesia induction until skin closure).The total count of lymph nodes harvested during the surgical procedure.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026